Leanne Harling interviews John McKenna about his experience in the device industry side of cardiothoracic surgery.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
February 18, 2020
This video shows the bioprosthetic failure of both aortic and mitral valves implanted 14 years ago in a patient.
January 30, 2020
Betsy Evans of Leeds General Infirmary in the United Kingdom presents a discussion on TAVI and surgery for prosthetic valve failure.
Minimally Invasive Direct Transcatheter Aortic Valve Replacement in Mitral Annular Calcification Implantation for Heavy Annular Calcification
January 14, 2020
This video demonstrates a right minithoracotomy direct implantation of a balloon expandable transcatheter aortic valve in heavy mitral annular calcification.
Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis (NOBLE): A Prospective, Randomised, Open-Label, Non-Inferiority Trial
January 10, 2020
''CABG was significantly better than PCI (p=0·0066........''
January 7, 2020
Dr Om Prakesh Yadava and Professor Vinayak Bapat discuss transcatheter approaches and sutureless valves implanted by minimally invasive approaches.
Carotid Versus Femoral Access for Transcatheter Aortic Valve Implantation: A Propensity Score Inverse Probability Weighting Study
January 3, 2020
The authors aimed to analyze the outcome of transcatheter aortic valve implantation (TAVI) via carotid arteries. Included are more than 10,000 patients. The study showed a similar two-year outcome regardless of access. Transcarotid TAVI was associated with higher risk of stroke but lower rate of access site complications.
December 4, 2019
Succinct commentary on the challenge of vascular access in ECMO circuits on the occasion of a manuscript on a novel design of a multi-access adaptor.
November 22, 2019
Puzzling subgroup from the GALILEO trial, which appears in the same issue of the periodical as an article that discredits the use of rivaroxaban as thromboprevention strategy :
November 7, 2019
Data from the PARTNER trials were assessed regarding post-procedural prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement and surgical aortic valve replacement. The timing and rates of PVE were similar between the groups, and they had a similar high mortality.